About 77,600 results
Open links in new tab
Patritumab Deruxtecan Demonstrated Statistically Significant
Patritumab Deruxtecan Demonstrated Statistically Significant ...
Patritumab Deruxtecan Meets PFS End Point in Pretreated EGFR …
Patritumab Deruxtecan BLA Submission Receives Complete …
Patritumab Deruxtecan Granted Priority Review in the U.S. for
Daiichi Sankyo and MSD’s ADC improves progression-free survival …
Patritumab Deruxtecan Demonstrated Statistically Significant ...
FDA Grants Breakthrough Therapy Status to Patritumab Deruxtecan …
- Some results have been removed